Loading clinical trials...
Loading clinical trials...
Postpartum anemia is a common condition associated with adverse maternal outcomes. This study aimed to compare the effectiveness of oral iron therapy versus intravenous iron therapy in women with postpartum anemia.
This randomized, open-label, parallel-group study was conducted at Shahida Islam Medical College and Hospital, Lodhran, Pakistan. Women diagnosed with postpartum anemia who fulfilled the eligibility criteria were randomly allocated using a lottery method to receive either intravenous iron (ferric carboxymaltose) or oral iron therapy (ferrous sulfate). The primary outcome was the change in hemoglobin level from baseline to 6 weeks of follow-up.
Age
20 - 40 years
Sex
FEMALE
Healthy Volunteers
No
Shahida Islam Medical College and Hospital, Lodhran
Lodhrān, Punjab Province, Pakistan
Start Date
February 18, 2025
Primary Completion Date
August 18, 2025
Completion Date
August 18, 2025
Last Updated
January 14, 2026
122
ACTUAL participants
Ferric Carboxy Maltose
DRUG
Ferrous Sulfate
DRUG
Lead Sponsor
Shahida Islam Medical Complex
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions